The result is measurable improvement in skin firmness, thickness, and elasticity over a full treatment cycle
Do the six RCTs in the meta-regression give any signal on which patient phenotype holds onto that residual loss, or is the data too heterogeneous to split out yet
That difference matters when someone plans long-term treatment
Safety, however, remains a priority, and any decision regarding the duration of Semaglutide use should be made in consultation with healthcare professionals
Zhao H, Li J, Li X, Han C, Zhang Y, Zheng L, Guo M
Retrieved from American College of Obstetricians and Gynecologists